• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The Troubling Trends Pointing to a Severe Flu and RSV Season
Flu and respiratory syncytial virus (RSV) season has just begun in the northern hemisphere, and the consensus among experts is that the 2022-2023 season is shaping up to be more severe than in the past few (relatively mild) years. It might even be worse than seasons before COVID-19. Health data company IQVIA has been analyzing data from insurance claims filed by doctors’ offices, hospitals, and urgent care centers in the country for three decades, and focused on case trends over the previous year. The team found that diagnoses of flu are already tracking at record highs. Even before flu season began, back in spring 2...
Source: TIME: Health - October 25, 2022 Category: Consumer Health News Authors: Alice Park and Charts by Emily Barone Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

How the Delta Variant Affects Whether You Should Wear a Mask or Not
As infections involving the new Delta variant of the COVID-19 virus continue to increase around the world, including in the U.S., health experts are yet again revisiting advice about who should wear masks and when. On June 28, the Los Angeles County public health department advised all people, including those who are vaccinated, to wear masks in most indoor public settings, based on the fact that nearly half of the virus from cases in the county that were genetically sequenced now belong to the Delta variant. The variant, first identified in India, is far more contagious than previous strains of SARS-CoV-2, and could cause...
Source: TIME: Health - July 1, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Current Clinical Trials in Pemphigus and Pemphigoid
Conclusions The clinical trials discussed here, which include several trials investigating novel therapeutic targets, demonstrate that translational research in pemphigus and pemphigoid is a fast-growing field. We thus expect that several novel treatments will be shortly available for the treatment of pemphigus and pemphigoid patients. Given the high, and thus far unmet, medical need in this field (110), this is highly encouraging and will hopefully improve the quality of life of the affected patients. In addition to the compounds and targets described here, several new targets have been recently identified in preclinical...
Source: Frontiers in Immunology - May 2, 2019 Category: Allergy & Immunology Source Type: research